| 000 | 01564 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514000205.0 | ||
| 264 | 0 | _c20011101 | |
| 008 | 200111s 0 0 eng d | ||
| 022 | _a0961-2033 | ||
| 024 | 7 |
_a10.1191/096120301680416931 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMosca, M | |
| 245 | 0 | 0 |
_aTherapy with pulse methylprednisolone and short course pulse cyclophosphamide for diffuse proliferative glomerulonephritis. _h[electronic resource] |
| 260 |
_bLupus _c2001 |
||
| 300 |
_a253-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGlomerulonephritis, Membranoproliferative _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylprednisolone _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aNeri, R | |
| 700 | 1 | _aGiannessi, S | |
| 700 | 1 | _aPasquariello, A | |
| 700 | 1 | _aPuccini, R | |
| 700 | 1 | _aBencivelli, W | |
| 700 | 1 | _aBombardieri, S | |
| 773 | 0 |
_tLupus _gvol. 10 _gno. 4 _gp. 253-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1191/096120301680416931 _zAvailable from publisher's website |
| 999 |
_c11274087 _d11274087 |
||